Search Orphan Drug Designations and Approvals
-
Generic Name: | adenoviral vector expressing human papillomavirus (HPV) 6 and HPV 11 antigens |
---|---|
Date Designated: | 03/17/2021 |
Orphan Designation: | Treatment of recurrent respiratory papillomatosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Precigen, Inc. 20358 Seneca Meadows Pkwy Germantown, Maryland 20876 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-